Recent research presented at a prominent European cardiology conference has raised concerns about xylitol, a popular sugar substitute found in many everyday products. The study, involving over 17,700 participants, indicates that elevated blood levels of xylitol may be linked to an increased risk of heart attacks, strokes, and even death, adding to the ongoing debate regarding the long-term cardiovascular safety of this sweetener.

The Study Overview
The findings were shared at the European Society of Cardiology Congress in Germany. The research team analyzed data from two extensive longitudinal studies: the European Prospective Investigation into Cancer (EPIC) Norfolk in the UK and the Canadian Longitudinal Study on Aging (CLSA).
Notably, participants in the Canadian cohort with the highest blood xylitol levels experienced a 57% higher risk of major cardiovascular events over a six-year follow-up compared to those with the lowest levels. In the UK cohort, followed for an impressive 30 years, the highest xylitol levels correlated with an 18% increased risk of similar events.
Cardiovascular Implications
Dr. Marco Witkowski from Charité University Hospital in Berlin, who presented the study, emphasized the limited understanding of xylitol’s long-term cardiovascular effects. He noted that many consumers believe artificial sweeteners are healthier alternatives to sugar, a perception supported by regulatory agencies. However, this research highlights a critical gap in knowledge regarding xylitol’s safety.
Both study cohorts demonstrated a dose-dependent relationship, meaning that as blood xylitol levels rose, so too did the incidence of cardiovascular events. This pattern persisted even after adjusting for several influencing factors, such as age, sex, body mass index, hypertension, diabetes, and cholesterol levels.
Building on Previous Research
These findings complement earlier work conducted by Dr. Stanley Hazen, a leading figure in cardiovascular and metabolic sciences at the Cleveland Clinic. His 2024 study revealed that individuals with higher xylitol levels had roughly double the risk of heart-related events over three years compared to those with lower levels.
Hazen’s research also involved laboratory experiments to observe the effects of xylitol on blood clotting. Participants who consumed a xylitol-sweetened beverage showed significant increases in platelet activity, which is crucial for clot formation. Similar results were observed in animal studies and isolated human blood samples, suggesting a biological mechanism that may explain the cardiovascular risks associated with xylitol.
Calls for Further Investigation
Dr. Hazen advocated for more in-depth research on sugar alcohols and artificial sweeteners, particularly as they are frequently recommended to patients managing obesity or diabetes. He underscored the urgent need to reassess how these substances are classified and regulated, especially in light of emerging evidence regarding their potential cardiovascular risks.
His concerns extend to how the FDA classifies xylitol as “Generally Recognized as Safe” (GRAS), indicating that it is considered harmless under typical conditions of use. Hazen has urged for regulatory changes that would improve labeling and ensure consumers are better informed about the potential risks associated with sugar substitutes.
Common Uses of Xylitol
Xylitol, a sugar alcohol, is commonly used as a low-calorie sweetener in products like chewing gum, candy, baked goods, and dental care items. It is valued for its ability to prevent tooth decay, and in the European Union, it is approved under the food additive designation E967.
Observational Nature of Findings
It’s important to note that the findings of both the new study and Hazen’s earlier research are observational. They indicate an association rather than proving a direct causation between xylitol and cardiovascular events. The European Society of Cardiology has acknowledged the need for further research to clarify whether these relationships reflect a causal effect or if other unmeasured factors are at play.
Regulatory Considerations
Artificial sweeteners, including xylitol, undergo rigorous safety testing prior to regulatory approval in markets like the United States and the European Union. They have long been recommended by health authorities as alternatives to added sugar for individuals managing weight, diabetes, or other metabolic conditions. The new findings contribute to an evolving understanding of xylitol’s safety profile, rather than providing a definitive conclusion.
Guidance for Consumers
Experts recommend that individuals with concerns about sugar substitutes consult their healthcare providers or registered dietitians, especially those with existing cardiovascular risk factors or conditions like diabetes. Making dietary changes based solely on observational data may not be advisable without professional guidance.
Future Research Directions
As scrutiny surrounding xylitol and other sugar alcohols intensifies, researchers anticipate the need for additional large-scale, long-term studies. These investigations will be essential to thoroughly characterize the cardiovascular safety of xylitol, particularly given its increasing use in a variety of consumer products marketed as healthier alternatives.
In summary, while xylitol is widely consumed and often viewed as a safe option, emerging research highlights significant potential risks associated with its use. Continued investigation will be crucial in determining its true impact on cardiovascular health.
- Key Takeaways:
- Elevated xylitol levels may increase the risk of heart attacks and strokes.
- The study involved over 17,700 participants from two major studies.
- Current findings emphasize the need for further research on sugar substitutes.
- Regulatory reassessment of xylitol’s safety classification is being urged.
- Consultation with healthcare professionals is recommended for those using sugar substitutes.
Read more → www.ibtimes.com.au
